Cargando…
miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()
Cancer-testis (CT) antigens are a large family of genes that are selectively expressed in human testis germ cells, overexpressed in a variety of tumors and predominantly located on the X chromosome. To date, all known CT antigens are protein-coding genes. Here, we identify miR-888 as the first miRNA...
Autores principales: | Hovey, Adriann M., Devor, Eric J., Breheny, Patrick J., Mott, Sarah L., Dai, Donghai, Thiel, Kristina W., Leslie, Kimberly K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415123/ https://www.ncbi.nlm.nih.gov/pubmed/25926074 http://dx.doi.org/10.1016/j.tranon.2015.02.001 |
Ejemplares similares
-
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014) -
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
por: Kavlashvili, Tamar, et al.
Publicado: (2016) -
miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer
por: Gao, Su-Jun, et al.
Publicado: (2018) -
miR-888: Hit it when you see it!
por: Bader, Andreas G
Publicado: (2014) -
Past, present, and future of hormonal therapy in recurrent endometrial cancer
por: Carlson, Matthew J, et al.
Publicado: (2014)